PSA Test Explained: Normal Range by Age, High PSA Causes & Prostate Cancer Risk (India) | प्रोस्टेट (PSA) टेस्ट गाइड: हाई PSA का मतलब कैंसर है?

PSA Test Explained: Normal Range by Age, High PSA Causes & Prostate Cancer Risk (India 2026)

प्रोस्टेट PSA टेस्ट गाइड: उम्र के अनुसार नॉर्मल रेंज, हाई PSA के कारण — क्या हाई PSA का मतलब हमेशा कैंसर है?

A plain-language guide for patients & families · भारतीय मरीज़ों और परिवारों के लिए सरल मार्गदर्शिका

Difficulty starting urination, a weak stream, waking up twice or more at night to urinate, a sense of incomplete bladder emptying — and your doctor has ordered a PSA test. Or perhaps a routine health check has returned a PSA of 5.8 ng/mL and you are wondering whether that means cancer. PSA (Prostate-Specific Antigen) is the most widely ordered prostate test in India — and one of the most anxiously misinterpreted. A high PSA does not mean prostate cancer. BPH (benign prostatic hyperplasia — simple prostate enlargement), prostatitis (prostate infection), and even vigorous cycling can elevate PSA dramatically. Conversely, prostate cancer can occasionally be present with a normal PSA. This guide explains exactly what PSA measures, how to interpret it correctly by age, what the common non-cancer causes of high PSA are, and when a urologist referral is genuinely needed.

If your doctor also ordered a CBC or ESR as part of a broader health screening, see those guides. For understanding lab reports in general, see our beginner's guide to blood test reports.

Urination में difficulty, रात को बार-बार उठना, पेशाब की कमज़ोर धार — और डॉक्टर ने PSA test लिखा। या health check में PSA 5.8 आया और घबराहट है। ज़रूरी बात: High PSA का मतलब हमेशा cancer नहीं। BPH (prostate enlargement), prostatitis, और cycling भी PSA बढ़ाते हैं। यह guide आपको सही interpretation करना सिखाएगी।

Table of Contents / विषय सूची

1. What Is PSA? / PSA क्या है?
2. Normal Range by Age / उम्र के अनुसार नॉर्मल रेंज
3. High PSA — Causes Beyond Cancer / PSA बढ़ने के कारण
4. PSA Density, Velocity & Free PSA — Advanced Interpretation
5. When to Worry — Prostate Cancer Signs & Biopsy Decision
6. PSA Screening in India — Who Should Test & When
7. Test Preparation Checklist / टेस्ट की तैयारी
8. Frequently Asked Questions / अक्सर पूछे जाने वाले सवाल

Image 1: The prostate gland — anatomy and why enlargement causes urinary symptoms. The prostate is a walnut-sized gland (~20 mL in young men) that sits directly below the bladder and surrounds the urethra (the tube through which urine passes from the bladder). Its primary function is to produce the fluid component of semen. Because the urethra passes through the centre of the prostate, any increase in prostate size — whether from BPH (benign enlargement), prostatitis (inflammation/infection), or cancer — compresses the urethra and causes urinary symptoms: difficulty initiating urination, weak stream, incomplete emptying, and nocturia (waking at night to urinate). PSA (Prostate-Specific Antigen) is a protein produced by prostate cells and secreted into both semen and blood — larger or more inflamed prostates produce more PSA, which is why PSA rises in BPH and prostatitis as well as cancer.

50–60% of Indian men above 60 have symptomatic BPH (benign prostatic hyperplasia) — the most common cause of elevated PSA in India. BPH is not cancer and does not cause cancer. Yet it is the condition most likely to produce a high PSA result in an Indian health check — and the most common source of unnecessary prostate cancer anxiety.

Age-specific ranges A PSA of 3.5 ng/mL at age 45 is significantly more concerning than the same value at age 72. PSA naturally rises with age as the prostate enlarges — using a single cut-off of 4.0 ng/mL for all ages misses early cancer in younger men and triggers unnecessary biopsies in older men. Always interpret PSA using age-specific reference ranges.

Free:Total PSA ratio When Total PSA is in the "grey zone" (4–10 ng/mL), the Free PSA percentage is the most important next step. Free PSA below 10% strongly suggests cancer. Free PSA above 25% strongly suggests BPH. This ratio alone can prevent many unnecessary prostate biopsies in Indian men with mildly elevated PSA.

---

What Is PSA?

PSA (Prostate-Specific Antigen) is a serine protease enzyme produced almost exclusively by the epithelial cells of the prostate gland. Its physiological role is to liquefy semen after ejaculation, enabling sperm to swim freely. Small amounts of PSA leak into the bloodstream from prostate tissue — these circulating blood levels are what the PSA blood test measures.

PSA (Prostate-Specific Antigen) एक enzyme है जो prostate gland की cells बनाती हैं। इसका काम semen को liquefy करना है। थोड़ा PSA blood में leak होता है — यही PSA blood test measure करता है। बड़ा या inflamed prostate ज़्यादा PSA leak करता है।

Why PSA rises — the four mechanisms that elevate blood PSA:

• 1. Increased prostate volume (BPH): More prostate cells = more PSA produced. BPH (benign prostatic hyperplasia) is simple age-related prostate enlargement — not cancer. A man with a 60 mL prostate (3× normal) will produce approximately 3× as much PSA as a man with a normal 20 mL prostate, regardless of whether cancer is present. This is why age-adjusted and volume-adjusted PSA (PSA density) are more informative than raw PSA alone.
• 2. Disrupted prostate architecture (Cancer): Prostate cancer disrupts the normal glandular architecture of the prostate, causing much larger amounts of PSA to leak into the bloodstream per unit of tissue volume than BPH does. This is the key biological difference — cancer PSA leaks more efficiently than BPH PSA. However, the overlap in absolute PSA values between BPH and cancer is extensive, which is why PSA interpretation requires multiple parameters.
• 3. Inflammation (Prostatitis): Bacterial or non-bacterial prostatitis causes intense inflammation that dramatically disrupts the prostate-blood barrier → massive acute PSA leakage. Acute bacterial prostatitis can elevate PSA to 50–200+ ng/mL. Even after antibiotic treatment and clinical resolution, PSA may remain elevated for 6–8 weeks.
• 4. Physical disruption (DRE, biopsy, catheterisation, cycling): Any mechanical disruption of the prostate increases PSA leakage transiently. Digital rectal examination (DRE) raises PSA for 24–48 hours. Prostate biopsy raises PSA for 4–6 weeks. Prolonged vigorous cycling (saddle pressure) raises PSA for 24–72 hours. These are pre-analytical sources of falsely elevated PSA that must be excluded before interpreting results.

PSA क्यों बढ़ता है: 1. BPH (बड़ा prostate = ज़्यादा PSA cells) — cancer नहीं। 2. Cancer (architecture disrupted → ज़्यादा leak per volume)। 3. Prostatitis (inflammation → massive PSA leak, 50–200+)। 4. Physical disruption (cycling, DRE, biopsy)। इसीलिए single high PSA = panic नहीं — cause identify करें।

---

Normal Range by Age — PSA

*PSA reference ranges vary between labs and assay platforms. The age-specific ranges below are widely accepted in Indian urology practice and consistent with AUA (American Urological Association) and EAU (European Association of Urology) guidelines. Units: ng/mL (nanograms per millilitre). Always check the reference range on your specific lab report.

Age Group	Normal PSA (ng/mL)	Borderline / Grey Zone	Elevated — Further Assessment
40–49 years	<2.5 ng/mL	2.5–4.0 ng/mL	>4.0 ng/mL
50–59 years	<3.5 ng/mL	3.5–5.0 ng/mL	>5.0 ng/mL
60–69 years	<4.5 ng/mL	4.5–6.5 ng/mL	>6.5 ng/mL
70+ years	<6.5 ng/mL	6.5–8.0 ng/mL	>8.0 ng/mL
Traditional single cut-off (all ages)	4.0 ng/mL — still used by many Indian labs as a single reference point regardless of age; clinically suboptimal but widely reported. A PSA of 3.8 ng/mL at age 45 is flagged "normal" by this approach but deserves urgent urologist evaluation.

Age-specific ranges: 40–49: <2.5; 50–59: <3.5; 60–69: <4.5; 70+: <6.5 ng/mL। Indian labs अक्सर single cut-off (4.0) print करती हैं — यह age के हिसाब से wrong interpretation दे सकता है। 45 साल के आदमी का PSA 3.8 "normal" नहीं — urologist से मिलें।

⚠️ Critical PSA interpretation rules — Indian context:

• Always use age-specific ranges: Most Indian labs still print a single normal cut-off of 4.0 ng/mL regardless of age. This is clinically inadequate — a PSA of 3.8 at age 45 demands urologist evaluation; the same value at age 75 with known large BPH is far less concerning.
• A normal PSA does not rule out prostate cancer: Approximately 15–25% of prostate cancers — including some high-grade tumours — are detected in men with PSA below 4.0 ng/mL. A normal PSA provides reassurance but is not a guarantee. Digital rectal examination (DRE) by a urologist is a complementary tool that can detect cancer even with normal PSA.
• Rule out prostatitis before cancer workup: If urinary symptoms (burning, fever, painful urination) or fever are present alongside elevated PSA, treat prostatitis with antibiotics first and retest PSA after 6–8 weeks. A repeat PSA that normalises after antibiotics effectively rules out cancer as the cause of the initial elevation.
• PSA velocity matters: A rise of more than 0.75 ng/mL per year — even if absolute PSA remains within normal range — is associated with increased prostate cancer risk and warrants urologist evaluation.
• 5-alpha reductase inhibitors halve PSA: Finasteride (Finast, Proscar) and Dutasteride (Dutas), commonly prescribed in India for BPH, reduce PSA by approximately 50% after 6 months of use. A PSA result on these medications must be doubled to estimate the "true" PSA. Many Indian patients and doctors are unaware of this critical correction.

Age-specific ranges use करें। Normal PSA cancer rule out नहीं करता — 15–25% cancers PSA <4.0 में। Prostatitis है तो पहले antibiotics, फिर 6–8 हफ्ते बाद retest। PSA velocity >0.75/year = concern। Finasteride/Dutasteride PSA आधा कर देते हैं — इन दवाओं पर PSA result को ×2 करें।

---

High PSA — Causes Beyond Cancer

Image 3: The many causes of elevated PSA — most are not cancer. The diagram illustrates the full spectrum of conditions and activities that raise PSA. The largest contributors by frequency in Indian men: BPH (very common after 50 — accounts for the majority of mildly elevated PSA results in Indian health checks); acute bacterial prostatitis (can send PSA to 50–200 ng/mL — always check for urinary symptoms and fever before cancer workup); chronic prostatitis/CPPS (common in Indian men aged 30–50, often underdiagnosed, responsible for PSA 4–15 range with irritative urinary symptoms); vigorous cycling or horseback riding (saddle pressure compresses the prostate — PSA can rise by 30–50% for 24–72 hours); recent digital rectal examination or urinary catheterisation; and — less frequently — prostate cancer. The key message: PSA elevation is an invitation to investigate further, not a cancer diagnosis.

Benign Prostatic Hyperplasia (BPH) — #1 cause of elevated PSA in India BPH (प्रोस्टेट का बढ़ना) — भारत में PSA बढ़ने का सबसे आम कारण

BPH (benign prostatic hyperplasia) — simple age-related enlargement of the prostate — is by far the most common cause of an elevated PSA in Indian health checks. BPH affects over 50–60% of Indian men above 60 and nearly 80% above 70. It is not cancer, does not cause cancer, and does not increase cancer risk. However, because a larger prostate contains more PSA-producing cells, men with significant BPH will typically have PSA levels of 4–10 ng/mL — the "grey zone" — purely from prostate size, with no malignancy present. The ESR and CBC are typically normal in BPH. The investigation that most definitively differentiates BPH from cancer is the Free PSA percentage alongside a prostate ultrasound (TRUS — transrectal ultrasound) for volume measurement.

BPH: 60+ age के 50–60% Indian men में। Cancer नहीं, cancer नहीं होता। Large prostate = more PSA-producing cells → PSA 4–10 "grey zone" — purely from size। Free PSA % और prostate ultrasound (TRUS) BPH vs cancer differentiate करते हैं।

Prostatitis — the most dramatically PSA-elevating non-cancer cause प्रोस्टेटाइटिस — PSA को सबसे ज़्यादा बढ़ाने वाला non-cancer कारण

Prostatitis (inflammation or infection of the prostate) can elevate PSA more dramatically than any other benign cause — including cancer. Acute bacterial prostatitis (Type I prostatitis) causes PSA to spike to 50–200+ ng/mL within hours of onset. The mechanism: intense inflammation disrupts the prostate-blood barrier → massive PSA leakage. Clinical features: fever, severe perineal or low back pain, dysuria (burning on urination), frequency, and an exquisitely tender prostate on digital rectal examination. Chronic prostatitis/CPPS (Chronic Pelvic Pain Syndrome — Type III) is more insidious: it is extremely common in Indian men aged 30–50, produces PSA in the 4–15 ng/mL range, and presents with varying combinations of perineal pain, irritative urinary symptoms, and sexual dysfunction. A urine culture, urine microscopy, and expressed prostatic secretion (EPS) analysis help confirm the diagnosis. PSA after successful prostatitis treatment falls to baseline over 6–8 weeks — a normalised repeat PSA effectively rules out cancer as the cause of the original spike. Many Indian men are given prostate cancer diagnoses based on a PSA drawn during an episode of unrecognised prostatitis.

Prostatitis: PSA 50–200+ ng/mL तक। Acute: fever + burning urination + low back pain। Chronic prostatitis (CPPS): India में 30–50 age पुरुषों में common — PSA 4–15, irritative symptoms। Antibiotics के बाद 6–8 हफ्ते में PSA normalize → cancer rule out। Prostatitis के दौरान PSA से cancer diagnose न करें।

Physical activities & procedures that raise PSA Physical activities जो PSA बढ़ाती हैं

Several common physical activities and medical procedures transiently elevate PSA by mechanically disrupting prostate tissue or its vascular barrier — these are important pre-analytical confounders that must be excluded before interpreting a PSA result as pathologically elevated:

• Vigorous cycling / horseback riding: Saddle pressure directly compresses the perineum and prostate → PSA rises 30–50% above baseline for 24–72 hours. Indian men who cycle for transport or sport should avoid cycling for 48–72 hours before PSA testing.
• Digital rectal examination (DRE): The DRE performed by a urologist directly manipulates the prostate → PSA rises for 24–48 hours. PSA blood should be drawn before the DRE, not after.
• Prostate biopsy: Massive PSA elevation for 4–6 weeks post-biopsy. Never interpret PSA within 6 weeks of a prostate biopsy.
• Urinary catheterisation: Insertion of a urinary catheter can elevate PSA for 24–48 hours.
• Cystoscopy: Endoscopic examination of the bladder/urethra — PSA elevated for 24–48 hours.
• Ejaculation: Can mildly raise PSA for 24–48 hours — avoid sexual activity for 48 hours before PSA testing.

Cycling 48–72 घंटे पहले avoid करें। DRE से पहले PSA blood draw। Biopsy के 6 हफ्ते बाद PSA test नहीं। Catheterisation के 48 घंटे बाद। Ejaculation 48 घंटे पहले avoid करें। इन सब से PSA falsely high हो जाता है।

Medications that affect PSA — critical for Indian patients Medications जो PSA को affect करती हैं

Several commonly prescribed medications in India significantly alter PSA levels — knowledge of these interactions is essential for correct interpretation:

• 5-alpha reductase inhibitors — Finasteride (Finast, Proscar, Propecia), Dutasteride (Dutas, Avodart): These drugs, widely used in India for BPH and male pattern baldness, suppress PSA by approximately 50% after 6 months of use. A man on Finasteride with a PSA of 2.0 ng/mL effectively has a "true" PSA of 4.0 ng/mL. Failing to apply this correction leads to massively underestimating PSA and missing prostate cancer. Always double the PSA result in a patient on these medications.
• NSAIDs (Aspirin, Ibuprofen): Regular aspirin use may modestly reduce PSA by 10–15% through anti-inflammatory effects on the prostate.
• Statins: Some studies suggest statins modestly reduce PSA — a potential confounding factor in men on long-term statin therapy.
• Testosterone / androgen therapy: Raises PSA — PSA should be monitored in any man on testosterone replacement therapy.

Finasteride/Dutasteride (BPH, hair loss): PSA आधा कर देते हैं — result ×2 करें। India में बहुत common — बहुत missed। NSAIDs: PSA 10–15% कम। Statins: modest PSA reduction। Testosterone therapy: PSA बढ़ाती है — monitor करें।

Urinary tract infection (UTI) and urinary retention UTI और urinary retention

Urinary tract infections, while primarily bladder infections, can secondarily involve the prostate (ascending infection) and cause PSA elevation of 2–4× baseline. In older Indian men, acute urinary retention (complete inability to urinate — a medical emergency requiring immediate catheterisation) is frequently accompanied by dramatically elevated PSA due to the combination of obstructive uropathy and secondary prostate inflammation. PSA drawn during or immediately after urinary retention should be discarded — it will be unreliable. Repeat PSA 6–8 weeks after the acute event, on stable treatment (alpha-blocker or 5-ARI), for a meaningful baseline. The CBC in UTI typically shows elevated WBC count (leukocytosis) and elevated ESR — helpful context when interpreting a simultaneously elevated PSA.

UTI: PSA 2–4× बढ़ सकता है। Acute urinary retention: PSA dramatically elevated — unreliable। Retention और UTI के 6–8 हफ्ते बाद stable condition में retest। CBC में WBC बढ़ा + ESR elevated — UTI context में PSA interpretation helpful।

Symptoms pointing to prostate disease in Indian men Prostate disease के लक्षण जो PSA test trigger करते हैं

• LUTS (Lower Urinary Tract Symptoms): Hesitancy (difficulty starting urine flow), weak or interrupted stream, straining, terminal dribbling — suggestive of BPH
• Nocturia: Waking 2+ times per night to urinate — very common BPH symptom; also assess fluid intake and diabetes (HbA1c) as a cause
• Irritative symptoms: Frequency, urgency, burning — may suggest prostatitis or UTI
• Incomplete emptying: Sensation that bladder is not fully empty after urination
• Haematuria: Blood in urine — requires urgent urology evaluation regardless of PSA level
• Haematospermia: Blood in semen — may indicate prostatitis or, less commonly, prostate cancer
• Bone pain: Low back, hip, or pelvic pain in a man with high PSA — raises strong concern for advanced prostate cancer with bone metastasis
• Erectile dysfunction: Can coexist with BPH and prostatitis; may also be a side effect of BPH treatment (5-ARIs reduce libido/erectile function in some patients)

BPH symptoms: hesitancy, weak stream, nocturia, incomplete emptying। Prostatitis: frequency, burning, perineal pain। Cancer concern: bone pain + high PSA। Haematuria (blood in urine) = urgent urology। Nocturia के साथ HbA1c check करें — diabetes भी common cause।

---

PSA Density, Velocity & Free PSA — Advanced Interpretation

Image 2: The common presentation of prostate disease in Indian men — urinary symptoms that are too often dismissed as "normal ageing." Obstructive symptoms (weak stream, hesitancy, straining, terminal dribble, incomplete emptying, urinary retention) point primarily to BPH. Irritative symptoms (frequency, urgency, nocturia, dysuria) point toward prostatitis, UTI, or an overactive bladder. These symptoms occur along a continuum — many Indian men have a mix of both. The IPSS (International Prostate Symptom Score) is a validated questionnaire used by urologists to quantify symptom burden. Urologists in India typically combine PSA measurement with prostate volume assessment (prostate ultrasound — TRUS) and the IPSS score to guide treatment decisions. Note that urinary symptoms alone cannot distinguish BPH from prostate cancer — PSA, prostate ultrasound, and sometimes biopsy are required for definitive differentiation.

When Total PSA falls in the "grey zone" (4–10 ng/mL) — the range where BPH and cancer overlap most significantly — additional refinements of PSA interpretation dramatically improve the ability to distinguish benign from malignant disease and reduce unnecessary biopsies. These are the three most clinically useful refinements available in Indian labs:

जब Total PSA "grey zone" (4–10 ng/mL) में हो — BPH और cancer सबसे ज़्यादा overlap करते हैं — ये तीन advanced tools unnecessary biopsy बचाने में help करते हैं।

PSA Refinement	Formula / What It Measures	Benign (BPH) Pattern	Cancer Concern Pattern	Clinical Use
Free PSA % (Most important in grey zone)	(Free PSA ÷ Total PSA) × 100 Expressed as a percentage	>25% Free PSA — BPH likely	<10% Free PSA — Cancer concern; biopsy recommended	Most useful single refinement in 4–10 ng/mL grey zone. Can prevent 20–30% of unnecessary biopsies in Indian men.
PSA Density (PSAD)	Total PSA ÷ Prostate Volume (mL on TRUS ultrasound) Normal: <0.15 ng/mL/mL	<0.10 ng/mL/mL — BPH-driven PSA likely	>0.15 ng/mL/mL — Cancer more likely; urologist evaluation	Adjusts PSA for prostate size — essential for large prostates. Requires TRUS ultrasound for prostate volume.
PSA Velocity (PSAV)	Change in PSA per year (ng/mL/year) Requires ≥2 PSA measurements ≥12 months apart from the same lab	<0.75 ng/mL/year — Stable, likely benign	>0.75 ng/mL/year — Rapid rise; cancer concern even if PSA within normal range	Rate of PSA change over time — a rapidly rising PSA is more suspicious than a stable elevated PSA. Always use same lab for serial measurements.

How to use Free PSA % in practice — a worked example:

• Patient A: Total PSA = 6.2 ng/mL; Free PSA = 1.9 ng/mL → Free PSA % = (1.9 ÷ 6.2) × 100 = 30.6% → High free PSA → BPH highly likely → Watchful waiting + repeat in 12 months is reasonable
• Patient B: Total PSA = 6.2 ng/mL; Free PSA = 0.5 ng/mL → Free PSA % = (0.5 ÷ 6.2) × 100 = 8.1% → Very low free PSA → Prostate cancer strongly suggested → Urologist referral + TRUS-guided biopsy indicated
• Why the difference: Cancer-associated PSA binds more tightly to blood proteins (complexed PSA is higher, free PSA is lower). Benign BPH produces proportionally more free, unbound PSA. The ratio exploits this biological difference to discriminate without biopsy in a significant proportion of grey-zone patients.
• Requesting Free PSA in India: Ask for "Total PSA + Free PSA" when booking — some labs charge separately for Free PSA (typically ₹200–500 extra). Always order both from the same blood draw.

Free PSA %: Patient A: 6.2 total, 1.9 free → 30.6% → BPH likely, watchful waiting। Patient B: 6.2 total, 0.5 free → 8.1% → Cancer concern → biopsy। Cancer PSA ज़्यादा complexed होता है → free PSA कम। BPH में proportionally ज़्यादा free PSA। Indian labs में "Total PSA + Free PSA" specifically order करें।

---

When to Worry — Prostate Cancer Signs & Biopsy Decision

Prostate cancer — what makes PSA elevation suspicious Prostate cancer — PSA को suspicious बनाने वाले factors

No single PSA value diagnoses or excludes prostate cancer. The combination of findings that together make prostate cancer significantly more likely:

• PSA above age-specific range — particularly above 10 ng/mL (cancer probability rises sharply above 10)
• Free PSA below 10% — strongly suggests cancer
• PSA velocity above 0.75 ng/mL/year — rapid rise even within "normal" range
• PSA density above 0.15 — disproportionate PSA for prostate volume
• Hard, irregular, or asymmetric prostate on DRE — abnormal digital rectal examination findings are cancer-suspicious regardless of PSA level
• Bone pain — low back, hip, pelvis — suggests advanced cancer with skeletal metastasis
• PSA above 10 ng/mL + PSA density above 0.15 + Free PSA below 10% — this combination has a cancer probability above 60–70% and warrants biopsy without delay

Importantly, early prostate cancer is typically completely asymptomatic — urinary symptoms occur only when cancer is locally advanced or when concomitant BPH is the cause of symptoms. Waiting for symptoms is not a valid cancer screening strategy.

Cancer suspicious pattern: PSA age-specific range से above + Free PSA <10% + velocity >0.75/year + density >0.15 + abnormal DRE। PSA >10 + free PSA <10% + density >0.15 = cancer probability 60–70% → biopsy without delay। Early prostate cancer asymptomatic — symptoms का इंतज़ार नहीं करना चाहिए।

Prostate biopsy — when is it needed? Prostate biopsy — कब ज़रूरी है?

TRUS-guided prostate biopsy (transrectal ultrasound-guided biopsy) is the definitive diagnostic procedure for prostate cancer — it provides tissue for histopathological diagnosis (Gleason score, which grades cancer aggressiveness). Indications where biopsy is generally recommended in Indian clinical practice:

• PSA above 10 ng/mL after excluding prostatitis (treated and retested after 6–8 weeks)
• PSA in the grey zone (4–10) with Free PSA below 10–15%
• PSA density above 0.15 in the grey zone
• Abnormal DRE (hard nodule, asymmetry, loss of median sulcus) regardless of PSA level
• PSA velocity above 0.75 ng/mL/year on at least 2 serial measurements from the same lab
• mpMRI (multiparametric MRI) prostate showing a PI-RADS 4–5 lesion — MRI before biopsy is increasingly the recommended approach in India's tertiary centres

Biopsy कब: PSA >10 (prostatitis treat करके, retest के बाद)। Grey zone + Free PSA <10–15%। PSA density >0.15। Abnormal DRE। PSA velocity >0.75/year। mpMRI PI-RADS 4–5। India के tertiary centres में mpMRI before biopsy increasingly standard।

Active surveillance — not all prostate cancer needs immediate treatment Active Surveillance — सभी prostate cancer को treatment की ज़रूरत नहीं

An important and frequently misunderstood concept in Indian prostate cancer care: a diagnosis of prostate cancer does not automatically mean immediate surgery or radiation. Low-risk prostate cancer (PSA below 10, Gleason score 6 = Grade Group 1, clinical stage T1c–T2a) has an extremely low risk of metastasis or cancer-related death within 10–15 years. International guidelines (NCCN, EAU) recommend active surveillance for low-risk cancer — regular PSA monitoring, repeat biopsies, and MRI rather than immediate treatment. The goal: avoid the significant side effects of radical prostatectomy (urinary incontinence, erectile dysfunction) and radiation (bowel and bladder toxicity) for a cancer that may never cause harm during the patient's lifetime. Treatment is initiated only if PSA velocity accelerates, Gleason grade increases, or MRI shows progression. This "watchful waiting with planned intervention triggers" approach is appropriate for many Indian men with low-risk prostate cancer, particularly those above age 70.

Low-risk prostate cancer (PSA <10, Gleason 6): Active surveillance — तुरंत treatment नहीं। Regular PSA, repeat biopsy, MRI। Treatment तब जब: PSA velocity बढ़े, Gleason grade बढ़े, MRI progression। Surgery/radiation के side effects (incontinence, ED) avoid करना goal। 70+ age के Indian men में particularly appropriate।

PSA after prostate cancer treatment — monitoring for recurrence Treatment के बाद PSA — recurrence monitoring

In men who have been treated for prostate cancer (radical prostatectomy or radiation), PSA becomes the primary tool for monitoring recurrence. After radical prostatectomy (complete prostate removal), PSA should fall to essentially undetectable levels (<0.1 ng/mL) within 4–6 weeks. A PSA that fails to reach undetectable levels, or that rises again after reaching an undetectable nadir, indicates biochemical recurrence — residual or metastatic cancer. The definition of biochemical recurrence post-prostatectomy: PSA rising above 0.2 ng/mL on two consecutive measurements. Post-radiation therapy, PSA falls more gradually (over 18–36 months) to a nadir value; a rise of 2.0 ng/mL above the nadir constitutes biochemical recurrence (Phoenix definition). Regular PSA monitoring (every 3–6 months for the first 5 years, then annually) is essential for all treated prostate cancer patients. Alongside PSA monitoring, patients on long-term hormonal therapy (androgen deprivation therapy, ADT) for advanced prostate cancer should also monitor CBC and bone density, as ADT causes anaemia and osteoporosis.

Post-prostatectomy: PSA <0.1 होना चाहिए। PSA >0.2 on 2 measurements = biochemical recurrence। Post-radiation: nadir से 2.0 ng/mL rise = recurrence (Phoenix definition)। हर 3–6 महीने PSA monitor। ADT पर: CBC (anaemia) और bone density भी monitor।

---

PSA Screening in India — Who Should Test & When

Indian urologist-consensus recommendations on PSA screening — who, when, and how often:

• Age 40–45 with high-risk features: First-degree relative (father, brother) with prostate cancer, especially diagnosed below age 65; known BRCA2 or Lynch syndrome carrier. Baseline PSA at 40–45 in these men allows trajectory tracking and personalised surveillance.
• Age 50 — all Indian men: Baseline PSA measurement at age 50, regardless of symptoms. Prostate cancer is generally asymptomatic until locally advanced — waiting for symptoms defeats the purpose of screening.
• Age 50–70 with normal PSA (<1.0 ng/mL): Repeat every 3–5 years — low PSA at 50 is strongly protective against future prostate cancer risk.
• Age 50–70 with PSA 1.0–2.5 ng/mL: Repeat annually.
• Age 50–70 with PSA above age-specific range: Urologist referral within 4–6 weeks. Do not panic — investigate systematically as outlined in this guide.
• Above age 70–75 with no prior abnormal PSA: The benefit of PSA screening diminishes with age above 70–75 years. Most guidelines recommend against initiating new PSA screening above 75 in men with no prior elevated PSA, as lead-time bias and overdiagnosis risks outweigh benefits. Existing elevated PSA should still be monitored by a urologist.
• PSA + DRE together: PSA alone misses 15–25% of prostate cancers. A baseline digital rectal examination (DRE) by a urologist at age 50 (or 45 with risk factors) combined with PSA gives the most complete prostate cancer screen available without imaging.

Screening recommendations: High risk (family history, BRCA2): age 40–45 से। सभी Indian men: age 50 पर baseline PSA। PSA <1.0: 3–5 साल बाद retest। PSA 1.0–2.5: annually। PSA > age-specific range: 4–6 हफ्ते में urologist। 75+ पर new screening शुरू नहीं। PSA + DRE साथ: सबसे complete screen।

---

Test Preparation Checklist / टेस्ट की तैयारी

PSA is one of the tests most commonly affected by pre-analytical variables — getting the preparation right is essential to avoid a falsely elevated result that triggers unnecessary investigation and anxiety:

PSA सबसे ज़्यादा pre-analytical variables से affected tests में से एक है। Preparation सही न हो तो result falsely high आता है — unnecessary investigation और anxiety। ये rules strictly follow करें।

• ✓
  No vigorous cycling, horseback riding, or intense perineal pressure for 48–72 hours before the test. Saddle-based activities directly compress the perineum and prostate gland, causing transient PSA leakage into the bloodstream. PSA can rise by 30–50% above baseline for 24–72 hours after vigorous cycling. Many Indian men commute by bicycle or exercise on stationary bikes daily — always specify to stop cycling 48–72 hours before PSA testing. Normal walking is unaffected.
  Cycling, horseback riding: PSA 30–50% तक बढ़ता है। Test से 48–72 घंटे पहले बंद करें। Normal walking ठीक है।
• ✓
  No ejaculation for 48–72 hours before the test. Ejaculation can transiently elevate serum PSA for 24–48 hours. While the effect is modest (typically less than 1 ng/mL), it can push a borderline result into the "elevated" range and trigger unnecessary downstream investigation. Abstain for 48–72 hours before collection.
  Ejaculation PSA transiently बढ़ाता है। Test से 48–72 घंटे पहले abstain करें। Borderline result को elevated range में push कर सकता है।
• ✓
  PSA blood must be drawn before any digital rectal examination (DRE). If your appointment involves both a DRE and a PSA blood test, the blood must be drawn first. A DRE performed before the blood draw raises PSA for 24–48 hours. Remind both the phlebotomist and the examining doctor of this sequence. If DRE has already been performed at a previous appointment the same day, inform the lab — ideally postpone PSA collection by 48 hours.
  DRE PSA को 24–48 घंटे तक बढ़ाती है। Blood draw हमेशा DRE से पहले। Phlebotomist और doctor दोनों को remind करें।
• ✓
  Do not test during or within 6–8 weeks of an episode of prostatitis, UTI, or urinary retention. Active prostate inflammation or infection causes massive, transient PSA elevation (sometimes 10–50× normal) that has no diagnostic relevance to cancer. Testing during acute prostatitis is a major cause of unnecessary prostate cancer anxiety in India. Treat the infection first, allow 6–8 weeks for PSA to return to baseline, then retest. A PSA that normalises after antibiotic treatment effectively rules out cancer as the aetiology.
  Prostatitis/UTI/urinary retention के दौरान PSA test नहीं। Antibiotics treat करें, 6–8 हफ्ते बाद retest। Normalised PSA after antibiotics = cancer rule out।
• ✓
  Disclose all medications to your doctor — especially Finasteride and Dutasteride. Finasteride (Finast, Proscar, Propecia) and Dutasteride (Dutas, Avodart) are among the most commonly prescribed drugs in Indian urology and dermatology. They reduce PSA by 50% after 6 months — a patient on these drugs with a PSA of 2.5 ng/mL effectively has a "true" PSA of 5.0 ng/mL. This drug-induced PSA halving is perhaps the most dangerous missed interaction in prostate cancer screening in India, as it causes cancer to be screened at a falsely reassuring PSA level. Always double the PSA result in patients on these drugs.
  Finasteride (Finast, Proscar, Propecia) और Dutasteride (Dutas): PSA 50% कम करते हैं। Result को ×2 करें। India में बहुत commonly missed — cancer screening में सबसे dangerous interaction।
• ✓
  Do not test within 6 weeks of a prostate biopsy. Prostate biopsy causes tissue disruption and bleeding that massively elevates PSA for 4–6 weeks. Any PSA result within 6 weeks of biopsy is uninterpretable for cancer screening purposes. Post-biopsy PSA monitoring (for biochemical recurrence assessment after confirmed cancer treatment) follows different timing protocols established by the treating urologist.
  Prostate biopsy के 6 हफ्ते बाद PSA test। Biopsy के बाद PSA massively elevated होती है — uninterpretable।
• ✓
  Fasting is not required — but morning collection is preferred for consistency. PSA levels are not significantly affected by recent food intake. However, for serial monitoring (tracking PSA velocity over years), collecting at the same time of day under the same conditions — and always at the same NABL-accredited lab — ensures the most reliable trend data. Use the same laboratory for all serial PSA measurements: PSA assay values can vary by 10–20% between platforms, making cross-lab comparisons unreliable for velocity calculations.
  Fasting ज़रूरी नहीं। Serial monitoring के लिए: same time of day, same NABL lab। Cross-lab PSA velocity comparison unreliable — 10–20% inter-platform variation।
• ✓
  Order Free PSA alongside Total PSA if your result falls in the 4–10 ng/mL grey zone. If your PSA comes back in the grey zone, call your lab or doctor immediately and request Free PSA from the same blood sample (if same-day processing is possible) or schedule a repeat draw for Total + Free PSA together. The Free PSA percentage is the single most important additional test for avoiding unnecessary prostate biopsy in the grey zone. Specify "Total PSA + Free PSA" at the time of initial booking to avoid a repeat blood draw.
  PSA 4–10 ng/mL (grey zone) आए तो Free PSA भी order करें — same blood draw से। Total + Free PSA booking के समय specify करें। Grey zone में Free PSA percentage सबसे important next step है।

---

✅ Book PSA Test— Home Collection

No fasting required. Ensure no cycling or ejaculation for 48–72 hours before collection. Always use the same NABL-accredited lab for serial PSA monitoring:

Total PSA No fasting required · No cycling 48–72 hrs before · Blood drawn before any DRE · No prostatitis/UTI (treat first, retest after 6–8 weeks) · NABL-accredited lab · Same lab for all serial tests · Home collection · Digital report · Available across India

Book PSA Test →

Affiliate link: I may earn a small commission at no extra cost to you. PSA tests are available at government hospitals and PMJAY-empanelled facilities across India. Always have PSA results interpreted by a qualified urologist alongside Free PSA %, prostate volume (TRUS ultrasound), DRE findings, and clinical history. Never interpret PSA in isolation.

Total PSA order करें। Fasting नहीं। Cycling 48–72 घंटे पहले नहीं। DRE से पहले blood draw। Prostatitis है तो पहले treat करें। Same NABL lab पर serial tests। Results को urologist से TRUS और DRE के साथ interpret करवाएं।

Prostate Health Support — Evidence-Based Supplements

Two supplements with clinical evidence supporting prostate health and reduced prostate cancer risk — Selenium (consistently among the most evidence-supported micronutrients for prostate cancer prevention in epidemiological studies) and a comprehensive prostate support formula combining Saw Palmetto, beta-sitosterol, zinc, and lycopene. These supplements support prostate health as part of a healthy lifestyle — they are not a treatment for BPH, prostatitis, or prostate cancer, and do not replace PSA monitoring or urologist evaluation. Always consult your doctor before starting any supplement.

Zenith Nutrition Selenium 40 mcg — 120 Capsules

Selenium is one of the most studied micronutrients in prostate cancer prevention. Epidemiological studies consistently show that men with higher selenium status have lower prostate cancer incidence — the mechanism involves selenium's role as a cofactor for glutathione peroxidase, a critical antioxidant enzyme that protects prostate DNA from oxidative damage. The SELECT trial (Selenium and Vitamin E Cancer Prevention Trial) and subsequent meta-analyses established that selenium supplementation at appropriate doses (55–200 µg/day) is associated with reduced PSA velocity and reduced prostate cancer risk in selenium-deficient populations. India has notably selenium-deficient soils in many regions — a significant proportion of Indian men may be subclinically selenium-deficient, which increases oxidative prostate damage over years. Zenith Nutrition provides 40 µg per capsule — a physiologically appropriate dose within safe limits (upper tolerable intake: 400 µg/day). Note: selenium supplementation above 200 µg/day may paradoxically increase cancer risk — always stay within recommended doses and discuss with your doctor if taking multiple supplements.

Selenium: prostate cancer prevention का most studied micronutrient। India में selenium-deficient soils common → subclinical deficiency widespread। 40 µg/day = safe dose। Glutathione peroxidase cofactor → prostate DNA oxidative damage से protect। SELECT trial: selenium supplementation → reduced PSA velocity। >200 µg/day avoid करें। View on Amazon India

Affiliate link — small commission at no extra cost.

Now Foods Prostate Health Clinical Strength — 90 Softgels

This comprehensive prostate health formula combines the most evidence-supported botanical and micronutrient ingredients for BPH symptom management and overall prostate health: Saw Palmetto extract (320 mg/day standardised extract) — the most studied natural agent for BPH; multiple meta-analyses show meaningful improvement in IPSS score (urinary symptom burden), peak urinary flow rate, and nocturia, with a mechanism involving 5-alpha reductase inhibition (similar to Finasteride but at lower magnitude) and anti-inflammatory effects; Beta-sitosterol — plant sterol that independently reduces BPH-related urinary symptoms and improves flow; Pumpkin seed extract — anti-androgenic and 5-alpha reductase inhibitory effects; Zinc — the prostate has the highest zinc concentration of any tissue in the body; zinc deficiency is associated with increased prostate cancer risk; Lycopene — the red carotenoid in tomatoes, consistently associated with lower prostate cancer risk in epidemiological studies. Note: if you are on Finasteride or Dutasteride, inform your doctor before adding Saw Palmetto — additive 5-ARI effects may alter PSA further and affect monitoring. Importantly, this product does not replace urologist evaluation for elevated PSA — PSA must still be measured every 12 months in men using this supplement.

Prostate Health formula: Saw Palmetto 320 mg (BPH symptoms कम करता है — IPSS score improve), Beta-sitosterol (urinary flow improve), Zinc (prostate में highest concentration — deficiency = cancer risk), Lycopene (tomato carotenoid — prostate cancer risk कम)। Finasteride/Dutasteride पर हैं तो doctor को बताएं — Saw Palmetto additive 5-ARI effect। PSA monitoring continue करें। View on Amazon India

Affiliate link — small commission at no extra cost.

Know a father, husband, or brother above 50 who has never had a PSA test or who is anxious about a high PSA result? Share this guide — the right information prevents both missed cancer and unnecessary fear. क्या आपके घर में 50+ age के पिता, पति, या भाई ने कभी PSA test नहीं करवाया? या high PSA से घबराए हुए हैं? यह guide share करें — सही जानकारी cancer miss होने और unnecessary fear दोनों से बचाती है।

Share on WhatsApp

Related Tests / संबंधित जांचें

These tests are commonly ordered alongside PSA in prostate and general male health evaluation:

PSA के साथ ये जांचें prostate और general male health evaluation में अक्सर order होती हैं:

CBC (Complete Blood Count) ESR Test HbA1c — Diabetes & Nocturia Thyroid Profile (TSH) Vitamin B12 Test How to Read a Blood Test Report Urine Routine

---

Frequently Asked Questions / अक्सर पूछे जाने वाले सवाल

What is the normal PSA level by age in India?

Age-specific PSA reference ranges widely used in Indian urology practice: 40–49 years: below 2.5 ng/mL; 50–59 years: below 3.5 ng/mL; 60–69 years: below 4.5 ng/mL; 70+ years: below 6.5 ng/mL. Most Indian labs still print a single cut-off of 4.0 ng/mL regardless of age — this is clinically inadequate. A PSA of 3.8 ng/mL at age 45 is above the age-specific threshold and deserves urgent urologist evaluation, even though most lab reports would flag it as "normal." Similarly, a PSA of 5.2 ng/mL in a 72-year-old man with a known large prostate on BPH treatment is far less alarming than the same value in a 55-year-old. Always interpret PSA using the age-appropriate range, not the single 4.0 ng/mL cut-off printed by most labs.

उत्तर: 40–49: <2.5; 50–59: <3.5; 60–69: <4.5; 70+: <6.5 ng/mL। Indian labs अक्सर single 4.0 cut-off print करती हैं — यह age के हिसाब से wrong है। 45 साल में PSA 3.8 = urologist से मिलें; 72 साल में PSA 5.2 with large BPH = less alarming।

My PSA is 6.5 — does this mean I have prostate cancer?

A PSA of 6.5 ng/mL does not mean prostate cancer. The most likely causes of a PSA in this range in an Indian man are BPH (simple prostate enlargement — very common above age 55), chronic prostatitis, or a combination of both. The critical next steps: First, exclude prostatitis — if you have urinary burning, frequency, perineal pain, or fever, treat with antibiotics and retest PSA after 6–8 weeks. If PSA normalises, cancer is excluded as the cause. Second, order Free PSA from the same blood draw — a Free PSA above 25% strongly favours BPH; below 10% raises significant cancer concern. Third, a prostate ultrasound (TRUS) for prostate volume — calculate PSA density (PSA ÷ volume); if density is below 0.10, BPH-driven PSA is very likely. Finally, a urologist should perform a DRE. Only if Free PSA is low, PSA density is high, or DRE is abnormal should biopsy be recommended. Most men with a PSA of 6.5 do not have prostate cancer.

उत्तर: PSA 6.5 = cancer नहीं। Most likely BPH या prostatitis। Steps: Prostatitis exclude करें (antibiotics + 6–8 हफ्ते retest)। Free PSA order करें (>25% = BPH; <10% = cancer concern)। TRUS ultrasound: PSA density calculate करें। Urologist से DRE। Most men with PSA 6.5 को cancer नहीं होता।

What is Free PSA and why is it important?

PSA circulates in the blood in two forms: "complexed" PSA (bound to proteins) and "free" PSA (unbound). The Free PSA percentage = (Free PSA ÷ Total PSA) × 100. Cancer-associated PSA is predominantly complexed (bound) — meaning the free PSA fraction is proportionally lower in prostate cancer than in BPH. This biological difference allows the Free PSA % to distinguish cancer from BPH in the grey zone (4–10 ng/mL) without biopsy: Free PSA below 10% = cancer strongly suspected; biopsy recommended. Free PSA above 25% = BPH highly likely; watchful waiting and repeat PSA in 12 months is reasonable. Free PSA between 10–25% = intermediate; urologist's clinical judgement determines whether biopsy is warranted. Always order Free PSA alongside Total PSA when the result is expected in the grey zone — it is the single most important additional test for avoiding unnecessary prostate biopsy in Indian men.

उत्तर: Free PSA % = (Free ÷ Total) × 100। Cancer PSA ज़्यादा complexed। <10% = cancer concern → biopsy। >25% = BPH → watchful waiting। 10–25% = intermediate → urologist judgement। Grey zone में Free PSA = unnecessary biopsy से बचाने का सबसे important tool।

I take Finasteride for hair loss. How does this affect my PSA?

This is critically important and widely missed in India. Finasteride (sold as Finast, Propecia, and multiple generics) and Dutasteride (Dutas, Avodart) — prescribed for both BPH and male pattern baldness (androgenetic alopecia) — reduce PSA by approximately 50% after 6 months of use. This means your PSA result on these medications is a significant underestimate of the true PSA. To compare with age-specific reference ranges: always double the PSA result when interpreting it in a patient on Finasteride or Dutasteride. For example, a PSA of 2.0 ng/mL in a 52-year-old man on Finasteride actually represents an effective PSA of 4.0 ng/mL — which is above the age-specific threshold and warrants urologist evaluation. Many Indian men taking Finasteride for hair loss are unaware of this interaction, and their GPs may not think to apply the correction. Inform both your dermatologist (who may have prescribed Finasteride for hair loss) and any doctor reviewing your PSA of this effect.

उत्तर: Finasteride (Finast, Propecia) और Dutasteride (Dutas): PSA 50% कम। PSA result को ×2 करें। Example: 52 साल + Finasteride + PSA 2.0 → effective PSA 4.0 → age-specific threshold से above → urologist। Hair loss के लिए Finasteride लेने वाले Indian men को यह interaction पता नहीं होता — dermatologist और GP दोनों को बताएं।

At what age should Indian men start getting PSA tests?

For Indian men with average risk: baseline PSA at age 50, regardless of urinary symptoms (early prostate cancer is asymptomatic). If the baseline PSA is below 1.0 ng/mL, repeat every 3–5 years. If PSA is 1.0–2.5 ng/mL, repeat annually. For men with elevated risk — a first-degree relative (father or brother) diagnosed with prostate cancer, especially below age 65, or known BRCA2/Lynch syndrome carrier — begin PSA screening at age 40–45. Above age 70–75 with no prior elevated PSA, the benefit of continued PSA screening diminishes — most guidelines recommend against initiating new screening above 75. The PSA test should always be combined with a digital rectal examination (DRE) by a urologist for the most complete prostate cancer screen — PSA alone misses 15–25% of cancers.

उत्तर: Average risk: age 50 पर baseline PSA। PSA <1.0: 3–5 साल बाद retest। PSA 1.0–2.5: annually। High risk (family history, BRCA2): age 40–45 से शुरू। 75+ पर new screening नहीं — existing high PSA monitor करते रहें। PSA + DRE साथ = most complete screen।

My PSA was high but normalised after antibiotics — does that definitely rule out prostate cancer?

A PSA that rises significantly during an episode of prostatitis and then returns to the pre-prostatitis baseline after antibiotic treatment strongly suggests that the PSA elevation was driven by the infection rather than cancer. In clinical practice, this pattern is highly reassuring and effectively rules out prostate cancer as the cause of the initial PSA spike in the vast majority of cases. However, "normalised" must mean the PSA has returned to the pre-illness baseline — not merely reduced from the very high prostatitis level. If post-treatment PSA returns to a level that was already elevated before the prostatitis episode, further investigation (Free PSA, TRUS ultrasound, urologist evaluation) is still warranted. Additionally, a small number of prostate cancers can coexist with prostatitis — a normalised PSA after antibiotics does not eliminate the need for the scheduled annual PSA rechecks or for urologist evaluation of any new symptoms that develop.

उत्तर: Prostatitis के बाद PSA normalize = cancer as cause highly unlikely। "Normalize" = pre-illness baseline तक वापस आना — सिर्फ prostatitis level से कम होना नहीं। Pre-illness PSA already elevated था तो further investigation ज़रूरी। Annual PSA recheck और urologist evaluation continue करें।

---

External References / बाहरी संसाधन

• AUA (American Urological Association) — PSA Guidelines: AUA PSA Best Practice Statement
• MedlinePlus (NIH): PSA Test — Patient Information
• USI (Urological Society of India): USI — Indian Urology Guidelines & Resources

⚠️ Medical Disclaimer / चिकित्सा अस्वीकरण

This article is for educational purposes only. PSA results must be interpreted by a qualified urologist alongside Free PSA percentage, prostate volume (TRUS ultrasound), digital rectal examination findings, PSA velocity, and clinical history — never in isolation. A high PSA does not diagnose prostate cancer; a normal PSA does not exclude it. Never self-diagnose or delay urologist evaluation based on this guide. Acute urinary retention is a medical emergency requiring immediate hospital attendance. Prostate biopsy decisions must be made by a urologist after comprehensive clinical evaluation, not based on PSA alone.

यह लेख केवल शैक्षिक उद्देश्यों के लिए है। PSA को urologist से Free PSA %, TRUS ultrasound, DRE, और history के साथ interpret करवाएं — अकेले नहीं। High PSA = cancer diagnosis नहीं। Normal PSA = cancer rule out नहीं। Acute urinary retention = EMERGENCY — तुरंत hospital। Biopsy decision urologist का — PSA alone से नहीं।

Share on WhatsApp